Miles White - 2010 CEO Pay

Miles White - Abbott

Miles White, Abbott CEO

Total Compensation: $25.6 million

Details: After a rough year of declining company stock prices and FDA pressure that delayed new drug approvals, Abbott CEO and Chairman Miles White saw his total 2010 pay drop 2.5 percent to $25.6 million from 2009's $26.2 million. Although he received a two percent raise in base salary--to $1.89 million--White's stock awards took a significant 12 percent hit, accounting for the majority of his lost compensation.

The company is showing promise with its first quarter earnings in 2011, with an 18 percent rise in sales, in part thanks to its arthritis drug Humira. Its global revenue increased by 17.4 percent to $9.04 billion.

Abbott Labs News:
Abbott: Kaletra HIV med 'clobbered' by rivals
Abbott merges U.S., foreign pharma units under new chief
Abbott to axe another 1,900 jobs
Jury: Abbott breached GSK deal, but not competition law

Miles White - 2010 CEO Pay
Read more on

Suggested Articles

Just one week after inking a COVID-19 vaccine deal with the U.S. for 100 million doses, J&J reached a supply agreement twice that size with the EU.

Ahead of a critical flu season, AstraZeneca is upping its manufacturing efforts to deliver more FluMist doses than previously anticipated.

FDA handed NS Pharma’s Viltepso a speedy FDA nod based on the same dystrophin production data that supported two Sarepta drugs' approvals.